AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET

Company Participants

Tryn Stimart - Chief Legal & Compliance Officer

Carl Hansen - Chief Executive Officer & President

Andrew Booth - Chief Financial Officer

Conference Call Participants

Andrea Tan - Goldman Sachs

Antonia Borovina - Bloom Burton

Steven Mah - Cowen

Stephen Willey - Stifel

Malcolm Hoffman - BMO

Gaurav Goparaju - Berenberg

Operator

Good afternoon, and thank you, and welcome to AbCellera's Second Quarter 2023 Business Update Conference Call. My name is Jason, and I will be the facilitator for the audio portion of today's interactive broadcast. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions]

At this time, I'd like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer.

Tryn Stimart

Thank you. Good afternoon, and welcome to AbCellera's second quarter 2023 business update. We are pleased to have you with us today as we discuss the results announced in our press release issued after the market closed today, which you can find on our Investor Relations website.

With me on the call today are Dr. Carl Hansen, AbCellera's Chief Executive Officer and President; and Andrew Booth, AbCellera's Chief Financial Officer.

The webcast portion of this call contains a slide presentation that we will refer to during the call. If you are following along on the phone and wish to access the slide portion of this presentation, you may do so on the Investor Relations section of our website. For those of you who have access to the streaming portion of the webcast, please be aware that there may be a delay in that you will not be able to post questions via the web.

This presentation may contain forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements are based on management's current expectations and are subject to certain risks and uncertainties. Please review our SEC filings for certain risk factors that could impact our future performance. Our presentation and SEC filings are available on our Investor Relations website. Note that all dollars referred to during our call today are U.S. dollars.

Now I am pleased to turn the call over to Dr. Carl Hansen.

Carl Hansen

Thanks Tryn. In preparation for today's call, I was reflecting on conversations that we've had with investors over the past few years. In the best of cases, we've had the opportunity to build deep relationships, and a clear understanding of what we're doing as a company as well as trust in our ability to execute.